Journal
DERMATOLOGY
Volume 220, Issue 1, Pages 63-65Publisher
KARGER
DOI: 10.1159/000258675
Keywords
Leishmaniasis; Leishmania infantum; Cutaneous leishmaniasis, infliximab; Tumor necrosis factor alpha antagonists
Categories
Ask authors/readers for more resources
We report the first case of cutaneous leishmaniasis in a patient treated with infliximab. The species was Leishmania infantum, agent of both cutaneous leishmaniasis and visceral leishmaniasis. Cutaneous leishmaniasis occurred after the 9th infusion of infliximab in a patient who was suffering from ankylosing spondylitis. Copyright (C) 2009 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
